Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Evidence of clinical efficacy of ukrain in colorectal cancer

March 9, 1998

Overview of preclinical and clinical evaluation of Russian nitrosourea

March 9, 1998

S-1 demonstrates excellent antitumor activity in phase II

March 9, 1998

Lilly antifolate evaluated in phase II

March 9, 1998

Favorable phase I results obtained with G-3139 in NHL

March 9, 1998

Flavonoid intake reduces risk of death from CHD

March 4, 1998

Cyclopropane analogues as potent anti-HIV-1 agents

Feb. 26, 1998

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Feb. 25, 1998

Quinolone HIV integrase inhibitors prepared at Warner-Lambert

Feb. 24, 1998

Nucleoside analogues from BioChem Therapeutic show potential for HIV/AIDS

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.